Citius Pharmaceuticals Inc

NASDAQ:CTXR   3:59:51 PM EDT
2.15
+0.06 (+2.87%)
Earnings Announcements

Citius Pharmaceuticals, Inc. Reports Third Fiscal Quarter 2021 Financial Results And Provides General Business Update

Published: 08/12/2021 20:57 GMT
Citius Pharmaceuticals Inc (CTXR) - Citius Pharmaceuticals, Inc. Reports Third Fiscal Quarter 2021 Financial Results and Provides General Business Update.
Citius Pharmaceuticals Inc - $115.7 Million in Cash and Cash Equivalents As of June 30, 2021 to Develop Pipeline and Invest in Long-term Growth.
Citius Pharmaceuticals Inc - Qtrly Net Loss Was $5.8 Million.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.03

Next Quarter Revenue Guidance is expected to be $19.16 Million
Next Quarter EPS Guidance is expected to be $0.07

More details on our Analysts Page.